3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Neoplasms
11
Breast Neoplasms
8
Prostatic Neoplasms
4
Colorectal Neoplasms
4
Polycystic Ovary Syndrome
3
Neoplasm Metastasis
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Pancreatic cancer, adult
2
Ovarian Neoplasms
2
Lymphoma
2
Disease
2
Carcinoma, Hepatocellular
2
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Testicular Germ Cell Tumor
1
Stroke
1
Solitary Pulmonary Nodule
1
Skin Neoplasms
1
Sezary Syndrome
1
Retroviridae Infections
1
Renal Insufficiency
1
Prostate Cancer Metastatic
1
Pancreatic carcinoma, familial
1
Pancreatic Neoplasms
1
Ovarian Germ Cell Cancer
1
Oligomenorrhea
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Neoplastic Cells, Circulating
1
Interventions
Temozolomide
12
Magnetic Resonance Spectroscopy
9
Radiotherapy
6
Surveys and Questionnaires
5
Blood Specimen Collection
4
Transurethral Resection of Bladder
3
Surgical Procedures, Operative
3
Radiation
3
Perfusion Magnetic Resonance Imaging
2
Magnetic Resonance Imaging
2
Lomustine
2
Immunotherapy
2
Drug Therapy
2
Chemoradiotherapy
2
Amplified Fragment Length Polymorphism Analysis
2
regorafenib
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
gadodiamide
1
apatinib
1
Ultrasonography
1
Trail Making Test
1
Therapies, Investigational
1
Tablets
1
Standard of Care
1
Specimen Handling
1
Sampling Studies
1
Re-Irradiation
1
Quality of Life
1
Psychometrics
1
Proton Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Glioblastoma
×
Hematologic Tests
×
Clear all
NCT06717295
2026-01-02
CCANED-CIPHER
Dysplasia Diagnostics Limited
Recruiting
6,000 enrolled